Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alzheimer Disease
Anti-inflammatory function of AD drugs revealed
August 26th, 2005
The mechanism in anti-Alzheimer disease drugs that inhibits the production of a destructive, inflammation-causing protein in the brain has been revealed by researchers at the Hebrew University of Jerusalem. Their work, described in a recent issue of Annals of Neurology, is likely to lead to the development of more efficient drugs than are currently in use for treating Alzheimer disease as well as other neurological conditions resulting from infections, autoimmune diseases such as multiple sclerosis, or brain inflammation resulting from trauma or stroke. The research team working on this project was headed by Prof. Raz Yirmiya of the psychology...
Source: Drug Week (2005-08-26)
|
